Atrium Therapeutics, Inc. (RNA) — Analyst estimates
Consensus analyst estimates for Atrium Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 666.67K | -1.38 | 1 |
| 2027 | 19.64M | -1.51 | 1 |
| 2028 | 4.00M | -6.08 | 6 |
| 2029 | 1.61B | -4.5 | 4 |
| 2030 | 18.62M | -4.11 | 2 |
Consensus analyst estimates by fiscal year.